Polonezii de la Polpharma preiau compania românească Biofarm

Polish pharmaceutical company Polpharma is acquiring Romanian drug manufacturer Biofarm for approximately 1.1 billion zlotys, enhancing its presence in Romania. Biofarm will continue operations and receive investments for growth and innovation. The integration aims to expand Biofarm's products into new markets and introduce Polpharma's products in Romania. This acquisition reflects a broader trend of Polish companies expanding in the Romanian market.